SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-24
👔
UroGen Pharma Ltd.
@URGN_InsiderForm 4 Filing: BUTITTA CYNTHIA M Acquires (Grant) shares of $URGN
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
UroGen Pharma Ltd.
Ticker: $URGN
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-22
Shares: 18,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, BUTITTA CYNTHIA M, holds the title of Director at UroGen Pharma Ltd..
On 2026-06-22, the insider transacted 18,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
BUTITTA CYNTHIA M (Director) was granted $0 of $URGN
Post-Transaction Position: 10,000 shares
SEC Accession No: 0001437749-26-021513 (CIK: 1222082)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.